Rapid reduction of substantially increased myoglobin and creatine kinase levels using a hemoadsorption device (CytoSorb<sup>®</sup>)—A case report
Erich Moresco, Christopher Rugg, Mathias Ströhle, Matthias Thoma
Abstract
Abstract Rhabdomyolysis (RM) is a potentially life‐threatening entity that can lead to acute kidney injury (AKI). Continuous renal replacement therapy (CRRT) alone is known as effective therapy, but the additional use of a hemoadsorber (like CytoSorb ® ) might increase its efficacy.
Topics & Concepts
MedicineRhabdomyolysisMyoglobinRenal replacement therapyCreatine kinaseAcute kidney injuryReduction (mathematics)UrologyIntensive care medicineInternal medicineGeometryOrganic chemistryChemistryMathematicsMuscle and Compartmental DisordersDialysis and Renal Disease ManagementElectrolyte and hormonal disorders